UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039975
Receipt number R000045578
Scientific Title Consortium for pooled data analysis regarding hospitalized patients with heart failure in Japan
Date of disclosure of the study information 2020/06/01
Last modified on 2020/03/30 10:33:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Consortium for pooled data analysis regarding hospitalized patients with heart failure in Japan

Acronym

COOPERATE-HF-J

Scientific Title

Consortium for pooled data analysis regarding hospitalized patients with heart failure in Japan

Scientific Title:Acronym

COOPERATE-HF-J

Region

Japan


Condition

Condition

Acute Heart Failure Syndrome

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the current state of treatment for acute heart failure syndrome (AHFS) including in the emergency department (ED) and it's effect on prognosis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Combined endpoint of all-cause mortality and readmission due to heart failure within 1 year.

Key secondary outcomes

In-hospital death; all-cause mortality within 30 days/90 days/1 year after discharge; heart failure readmission rate within 30 days/90 days/1 year after discharge.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Unplanned hospitalization required for urgent care of acutely decompensated heart failure who are diagnosed according to Framingham criteria.

Key exclusion criteria

(1) Patients without consent
(2)
NARA-HF
1. Acute coronary syndrome
2. Acute myocarditis
3. Acute right heart failure with acute pulmonary embolism
REALITY-AHF
1. After cardiac transplantation
2. Chronic hemodialysis
3. Acute myocarditis
4. Acute coronary syndrome require emergent revascularization
WET-HF
1. Acute coronary syndrome
MEIDAI-HF
1. Patients judged by the attending physician or the investigator to be inappropriate

Target sample size

8500


Research contact person

Name of lead principal investigator

1st name Yuya
Middle name
Last name Matsue

Organization

Juntendo University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

0338133111

Email

yuya8950@gmail.com


Public contact

Name of contact person

1st name Kazutaka
Middle name
Last name Nogi

Organization

Nara Medical University

Division name

Department of Cardiovascular Medicine

Zip code

634-8522

Address

840 Shijo-cho, Kashihara, Nara, Japan

TEL

0744-22-3051

Homepage URL


Email

nogi18kazu@naramed-u.ac.jp


Sponsor or person

Institute

COOPERATE-HF-J

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nara Medical University Research Ethics Committee

Address

840 Shijo-cho, Kashihara, Nara, Japan

Tel

0744-22-3051

Email

ino_rinri@naramed-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

奈良県立医科大学(奈良)・亀田メディカルセンター(千葉)・慶應義塾大学(東京)・名古屋大学(愛知)・神戸市立医療センター中央市民病院(兵庫)・聖路加国際病院(東京)・聖マリアンナ医科大学(神奈川)・北里大学(神奈川)・東京医科大学茨城医療センター(茨城)・東京医科歯科大学(東京)・福島県立医科大学(福島)・筑波大学(茨城)・横浜市立大学附属市民総合医療センター(神奈川)・日本医科大学(東京)・日本医科大学武蔵小杉病院(神奈川)・心臓病センター榊原病院(岡山)・兵庫県立姫路循環器病センター(兵庫)・神戸百年記念病院(兵庫)・武蔵野赤十字病院(東京)・済生会福岡総合病院(福岡)・高知大学(高知)・滋賀県立成人病センター(滋賀)・赤穂市民病院(兵庫)・榊原記念病院(東京)・杏林大学(東京)・東京都済生会中央病院(東京)・国立病院機構東京医療センター(東京)・埼玉医科大学国際医療センター(埼玉)・防衛医科大学(埼玉)


Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 03 Month 25 Day

Date of IRB

2020 Year 06 Month 01 Day

Anticipated trial start date

2020 Year 06 Month 01 Day

Last follow-up date

2025 Year 06 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Elucidate the correlation between therapy for AHFS in the acute phase and prognosis by prospective multicenter registry in Japan.


Management information

Registered date

2020 Year 03 Month 29 Day

Last modified on

2020 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045578


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name